These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17142340)

  • 1. ANG II type 1 receptor antagonist irbesartan inhibits coronary angiogenesis stimulated by chronic intermittent hypoxia in neonatal rats.
    Rakusan K; Chvojkova Z; Oliviero P; Ostadalova I; Kolar F; Chassagne C; Samuel JL; Ostadal B
    Am J Physiol Heart Circ Physiol; 2007 Mar; 292(3):H1237-44. PubMed ID: 17142340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis related gene expression profiles of EA.hy926 cells induced by irbesartan: a possible novel therapeutic approach.
    Ma C; Lu XC; Luo Y; Cao J; Yang B; Gao Y; Liu XF; Fan L
    Chin Med J (Engl); 2012 Apr; 125(8):1369-75. PubMed ID: 22613637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
    Pu Q; Larouche I; Schiffrin EL
    Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCV-116 stimulates eNOS and caveolin-1 expression and improves coronary microvascular remodeling in normotensive and angiotensin II-induced hypertensive rats.
    Kobayashi N; Mori Y; Nakano S; Tsubokou Y; Kobayashi T; Shirataki H; Matsuoka H
    Atherosclerosis; 2001 Oct; 158(2):359-68. PubMed ID: 11583714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure.
    Watanabe R; Suzuki J; Wakayama K; Kumagai H; Ikeda Y; Akazawa H; Komuro I; Isobe M
    Hypertens Res; 2016 Apr; 39(4):237-44. PubMed ID: 26657004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
    Anjaneyulu M; Chopra K
    Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AT1 receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodeling post-MI.
    Nguyen QT; Colombo F; Clement R; Gosselin H; Rouleau JL; Calderone A
    Br J Pharmacol; 2003 Apr; 138(8):1485-94. PubMed ID: 12721104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
    Kawano H; Cody RJ; Graf K; Goetze S; Kawano Y; Schnee J; Law RE; Hsueh WA
    Hypertension; 2000 Jan; 35(1 Pt 2):273-9. PubMed ID: 10642310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of irbesartan and carvedilol on expression of tissue factor and tissue factor pathway inhibitor in rats after myocardial infarction.
    Yu J; Zhao J; Liu W; Ge Z; Du Y
    Heart Vessels; 2011 Nov; 26(6):646-53. PubMed ID: 21229253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.
    Marut W; Kavian N; Servettaz A; Hua-Huy T; Nicco C; Chéreau C; Weill B; Dinh-Xuan AT; Batteux F
    Arthritis Rheum; 2013 May; 65(5):1367-77. PubMed ID: 23335130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of angiotensin II AT1-receptor blockade on coronary dynamics, function, and structure in postischemic heart failure in rats.
    Gervais M; Fornes P; Richer C; Nisato D; Giudicelli JF
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):329-37. PubMed ID: 10975590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase].
    Zhang RY; Huang YL; Sun YH
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1053-6. PubMed ID: 16029550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of 5/6 nephrectomy rats with sulodexide: a novel therapy for chronic renal failure.
    Li P; Ma LL; Xie RJ; Xie YS; Wei RB; Yin M; Wang JZ; Chen XM
    Acta Pharmacol Sin; 2012 May; 33(5):644-51. PubMed ID: 22555371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
    Clasen R; Schupp M; Foryst-Ludwig A; Sprang C; Clemenz M; Krikov M; Thöne-Reineke C; Unger T; Kintscher U
    Hypertension; 2005 Jul; 46(1):137-43. PubMed ID: 15939809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb.
    Tamarat R; Silvestre JS; Kubis N; Benessiano J; Duriez M; deGasparo M; Henrion D; Levy BI
    Hypertension; 2002 Mar; 39(3):830-5. PubMed ID: 11897773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction.
    Schuijt MP; Basdew M; van Veghel R; de Vries R; Saxena PR; Schoemaker RG; Danser AH
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2590-6. PubMed ID: 11709427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved gastric emptying in diabetic rats by irbesartan via decreased serum leptin and ameliorated gastric microcirculation.
    He L; Sun Y; Zhu Y; Ren R; Zhang Y; Wang F
    Genet Mol Res; 2014 Sep; 13(3):7163-72. PubMed ID: 25222222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of cyclosporine nephrotoxicity by irbesartan, A selective AT1 receptor antagonist.
    Chander V; Singh D; Tirkey N; Chander H; Chopra K
    Ren Fail; 2004 Sep; 26(5):467-77. PubMed ID: 15526904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat.
    Jugdutt BI; Menon V
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):217-26. PubMed ID: 14506547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
    Morsing P; Adler G; Brandt-Eliasson U; Karp L; Ohlson K; Renberg L; Sjöquist PO; Abrahamsson T
    Hypertension; 1999 Jun; 33(6):1406-13. PubMed ID: 10373224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.